Issue

Vol. 66 No. 3: Issue 3

The undersigned hereby assign all rights, included but not limited to copyright, for this manuscript to CMB Association upon its submission for consideration to publication on Cellular and Molecular Biology. The rights assigned include, but are not limited to, the sole and exclusive rights to license, sell, subsequently assign, derive, distribute, display and reproduce this manuscript, in whole or in part, in any format, electronic or otherwise, including those in existence at the time this agreement was signed. The authors hereby warrant that they have not granted or assigned, and shall not grant or assign, the aforementioned rights to any other person, firm, organization, or other entity. All rights are automatically restored to authors if this manuscript is not accepted for publication.

Parenteral nutrition effects of Omega-3 fatty acids on C-reactive protein, high-density lipoprotein, lymphocyte characteristics and the treatment of critically ill patients

https://doi.org/10.14715/cmb/2020.66.3.8
Chunhua Ni
ICU, the First People's Hospital of Kunshan, Jiangsu, China
Jianxun Cao
Department of radiology, Gansu provincial people's hospital, Lanzhou, Gansu, China
Dechuan Li
Department of General Surgery, Baian Branch of Chongqing Three Gorges Central Hospital, Chongqing, China
Wei Wu
Emergency Department, Qinghai Provincial People's Hospital, Xining, Qinghai, China
Lei Cao
Department of Pediatrics, Gansu Provincial Maternity and Child-Care Hospital, Xining, Qinghai, China
Chaoyun Zhu
Emergency department, Yixing People's Hospital, Yixing, Jiangsu, China

Corresponding Author(s) : Chaoyun Zhu

jiancuichina52436@outlook.com

Cellular and Molecular Biology, Vol. 66 No. 3: Issue 3

Abstract

To study the effects of omega-3 fatty acid parenteral nutrition on the nutrition, inflammatory responses, immunity and prognoses of critically ill cancer patients. A total of 80 critically ill cancer patients were randomly divided into an observation group and a control group, 40 cases in each group. Both groups of patients received equal-nitrogen and equal-calorie enteral and parenteral nutrition. The observation group, on this basis, was added with omega-3 fatty acid parenteral nutrition. The weekly nutritional status measures, inflammatory response measures, immune function measures and prognosis measures (ICU mortality, ICU stay, infectious complications) of the two groups were observed. The nutrition, inflammatory response and immune measures of the observation group were improved compared with the control group. The ICU stay in the observation group was shorter than the control group. Compared with the control group, the ICU mortality rate and infectious complication rate were lower in the observation group, but the differences were not significant (P mortality = 0.13, P infection rate = 0.165). Omega-3 fatty acid parenteral nutrition could improve patients' nutritional status and immune function, reduce the body's inflammatory responses and shorten the length of hospital stay, but couldn't significantly improve ICU mortality and reduce the incidence of infectious complications.

Keywords

Omega-3 fatty acids Parenteral nutrition Critical illness Cancer patients.
Ni, C., Cao, J., Li, D., Wu, W., Cao, L., & Zhu, C. (2020). Parenteral nutrition effects of Omega-3 fatty acids on C-reactive protein, high-density lipoprotein, lymphocyte characteristics and the treatment of critically ill patients. Cellular and Molecular Biology, 66(3), 52–56. https://doi.org/10.14715/cmb/2020.66.3.8
Download Citation
Endnote/Zotero/Mendeley (RIS)
BibTeX
References
  1. Wang Y, Pan L, Sheng X, Mao Y, Yao Y, Wang E, et al. Reversal of cerebral radiation necrosis with bevacizumab treatment in 17 Chinese patients. Eur J Med Res. 2012; 17:25.
  2. Soares M，Caruso P，Silva E，et al. Characteristics and outcomes of patients with cancer requiring admission to inten⃠sive care units：a prospective multicenter study. Crit Care Med，2010;38（1）：9-15
  3. Yoshida M, Goto M, Kii T, Nishitani H, Kawabe S, Kuwakado S, et al. Retrospective study as first-line chemotherapy combined anti-VEGF antibody with fluoropyrimidine for frail patients with unresectable or metastatic colorectal cancer. Digestion. 2013; 87:59–64.
  4. Kondrup J，Rasmussen HH，Hamberg O，et al. Nutritional risk screening（NRS 2002）：a new method based on an analysis of controlled clinical trials. Clin Nutr，2003，22 （3）：321-336.
  5. Campbell RJ, Bell CM, Paterson JM, Bronskill SE, Moineddin R, Whitehead M, et al. Stroke rates after introduction of vascular endothelial growth factor inhibitors for macular degeneration: A time series analysis. Ophthalmology. 2012; 119:1604–8.
  6. Lach K，Peterson S J. Nutrition support for critically ill patients with cancer. Nutr Clin Pract， 2017（4）：884533617712488
  7. Campbell RJ, Gill SS, Bronskill SE, Paterson JM, Whitehead M, Bell CM. Adverse events with intravitreal injection of vascular endothelial growth factor inhibitors: Nested case-control study. BMJ. 2012; 345: e4203.
  8. Amit L, Ben-Aharon I, Vidal L, Leibovici L, Stemmer S. The impact of Bevacizumab (Avastin) on survival in metastatic solid tumors – A meta-analysis and systematic review. PLoS One. 2013; 8:e51780.
  9. Lu C，Sharma S，Mcintyre L，et al. Omegaâƒ3 supplementation in patients with sepsis：a systematic review and meta ⃠analysis of randomized trials. Ann Intensive Care，2017，7（1）：58.
  10. Rhodes A，Evans L E，Alhazzani W，et al. Surviving sepsis campaign：international guidelines for management of sepsis and septic shock：2016. Intensive Care Med，2017; 43（3）：304-377.
  11. Berger MM, Tappy L, Revelly JP, Koletzko BV, Gepert J, Corpataux JM, Cayeux MC, Chiolero RL. Fish oil after abdominal aorta aneurysm surgery. Eur J Clin Nutr. 2008; 16:1116-1122.
  12. Manzanares W，Dhaliwal R，Jurewitsch B，et al. Parenteral fish oil lipid emulsions in the critically ill：a systematic review and metaâƒanalysis. JPEN J Parenter Enteral Nutr 2014:38（1）：20-28.
  13. Friesecke S, Lotze C, Köhler J, Heinrich A, Felix SB, Abel P. Fish oil supplementation in the parenteral nutrition of critically ill medical patients: a randomised controlled trial. Intensive Care Med. 2008; 16:1411–1420.
  14. ï¼½ Heydari B，Abbasi SA，Shah R，et al． Effect of purified omega 3 fatty acids on reducing left ventricular remodeling after acute myocardial infarction (Omega Remodel study): a doubleï¼blind randomized clinical trial) J Cardiovascular Magn Reson 2015;17(1): 1ï¼3．
  15. Sabater J, Masclans JR, Sacanell J, Chacon P, Sabin P, Planas M. Effects of an omega-3 fatty acid-enriched lipid emulsion on eicosanoid synthesis in acute respiratory distress syndrome (ARDS): A prospective, randomized, double-blind, parallel group study. Nutr Metab (Lond) 2011; 16:22. doi: 10.1186/1743-7075-8-22.
  16. Hofman Z，Swinkels S，Van Zanten A R H. Gluta mine，fish oil and antioxidants in critical illness：MetaPlus tri⃠al post hoc safety analysis. Ann Intensive Care 2016; 6（1）：119.
  17. Piper SN, Schade I, Beschmann RB, Maleck WH, Boldt J, Röhm KD. Hepatocellular integrity after parenteral nutrition: comparison of a fish-oil-containing lipid emulsion with an olive-soybean oil-based lipid emulsion. Eur J Anaesthesiol. 2009; 16:1076–1082.
  18. Wang X, Li W, Zhang F, Pan L, Li N, Li J. Fish oil-supplemented parenteral nutrition in severe acute pancreatitis patients and effects on immune function and infectious risk: a randomized controlled trial. Inflammation. 2009; 16:304–309.
  19. Nosaka K，Doi M，Miyoshi T，et al． Early loading of omegaï¼3 fatty acids decreases inflammation and inï¼hospital events in patients with acute myocardial infarcton undergoing percutaneous coronary intervention． Journal of the American College of Cardiology，2014; 63(12): A38.
  20. Kazemi E, Kahrizi D. The repeatability of PCR-RFLP method for study of association between gastric cancer and manganese superoxide dismutase mutant (Val-9Ala). Biharean Biol 2017; 11(2), 112-114.
  21. Kazemi E, Kahrizi D. Lack of association between gastric cancer and hopq alleles in Helicobacter pylori. Genetika 2016; 48(3): 893-902
  22. Kazemi E, Kahrizi D, Moradi MT, Sohrabi M, Yari K. Gastric Cancer and Helicobacter pylori: Impact of hopQII Gene. Cell Mol Biol 2016; 62(2): 107-110.
  23. Kazemi E, Kahrizi D, Moradi MT, Sohrabi M, Amini A, Mousavi SAR, Yari K. Association between Helicobacter pylori hopQI genotyping and human gastric cancer. Cell Mol Biol 2016; 62(1): 6-9.
  24. Kazemi E, Kahrizi D, Moradi MT, Sorabi, M, Amini S, Mousavi S.A.R., Yari K. Association between Manganese Superoxide Dismutase (MnSOD Val-9Ala) genotypes with the risk of generalized aggressive periodontitis disease. Cell Mol Biol 2016; 61 (8): 49-52.
  25. Ghamarnia H, Kahrizi D, Rostami Ahmadvandi H. Camelina, a Low Input and Adaptable Plant. 2020; Razi University Press
  26. Fallah F, Kahrizi D, Rezaeizad A, Zebarzadi A, Zarei L. Evaluation of Genetic Variation and Parameters of Fatty Acid Profile in Doubled Haploid Lines of Camelina sativa L. Plant Genetic Res 2020; 6(2): 79-96.
  27. Soltani MF, Zebarjadi AR, Abdoli-Nasab M, Jalali Javaran M, Kahrizi D. Isolation and Characterization of Delta 15 Desaturase (FAD3) Gene from Camelina sativa L. J Appl Biotechnol Rep. 2020; 7(1):48-52.
  28. Soltani MF. Zebarjadi AR, Abdoli-Nasab M, Jalali Javaran M., Kahrizi D. Isolation and Characterization of Delta 15 Desaturase (FAD3) Gene from Camelina sativa L. J Appl Biotechnol Rep 2020; 7(1):48-52
  29. Soltani MF. Zebarjadi AR, Abdoli-Nasab M, Jalali Javaran M., Kahrizi D. Camelina sativa cultivar DKDH0065 omega-3 fatty acid desaturase (FAD3) mRNA, complete cds. Patent in NCBI. In: https://www.ncbi.nlm.nih.gov/nuccore/MG253926. 2018.
  30. Mohammadi-Nejad R, Bahramian S, Kahrizi D. Evaluation of physicochemical properties, fatty acid composition and oxidative stability of Camelina sativa (DH 1025) oil. Food Sci Technol 2018; 15 (77) :269-261.
  31. Bordbar M, Darvishzadeh R, Pazhouhandeh M, Kahrizi D. An overview of genome editing methods based on endonucleases. Modern Genetics J 2020; 15(2): 75-92.
  32. Raziei Z, Kahrizi D, Rostami-Ahmadvandi H. Effects of climate on fatty acid profile in Camelina sativa. Cell Mol Biol 2018; 64(2): 91-96.
Read More
Author biographies is not available.
Crossref
Scopus
Google Scholar
Europe PMC
Download this PDF file
PDF
Statistic
Read Counter : 1005 Download : 538